To further validate the expression levels of newly identified pivotal and consistant DEGs in AA and EA PCa, KRT15 and KRT19 protein expression levels were validated by Immunohistochemistry (IHC) in prostate tumor samples (Figure 2D). This evidence concerns the gene KRT15 and prostate neoplasm.